They also suggest that the T790M clone may become dispensable for TKI-resistance after the phenotypic transition to SCLC [195,197,200], possibly because the EGFR protein downregulation represents a sort of “loss of TKI-target”. The gene discussed is EGFR; the disease is small cell lung carcinoma.